medcalc version 19.6.4 (MedCalc Software Ltd)
90
Structured Review
MedCalc Software Ltd
medcalc version 19.6.4
Medcalc Version 19.6.4, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/medcalc+version+19%2E6%2E4/medcalc+9+0+1/pm39980145-48-0-3
Average 90 stars, based on 1 article reviews
Medcalc Version 19.6.4, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/medcalc+version+19%2E6%2E4/medcalc+9+0+1/pm39980145-48-0-3
Average 90 stars, based on 1 article reviews
medcalc version 19.6.4 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Pembrolizumab in Patients with Advanced Urothelial Carcinoma with ECOG Performance Status 2: A Real-World Study from the ARON-2 Project. Article Snippet: Background The benefit of immune checkpoint inhibitors (ICIs) for poor performance status patients with advanced urothelial carcinoma (UC) remains unknown.. Objective In the present sub-analysis of the ARON-2 study, we investigated the role of pembrolizumab for advanced UC patients with ECOG (Eastern Cooperative Oncology Group) performance status (ECOG-PS) 2.. Patients and Methods Patients aged ≥ 18 years with a cytologically and/or histologically confirmed diagnosis of advanced UC progressing or recurring after platinum-based therapy and treated with pembrolizumab between 1 January 2016 to 1 April 2024 were included. Article Title: Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2 EV Study. Article Snippet: Statistical analyses were conducted using Article Title: Left atrial pump strain predicts long-term survival after transcatheter aortic valve implantation. Article Snippet: Statistical analyses were performed using Article Title: Predictive risk factors for one-year mortality in idiopathic inflammatory myopathy patients with interstitial lung disease: A retrospective, single-center cohort study Article Snippet: Statistical analysis Statistical analysis was performed using IBM SPSS version 23.0 software (IBM Corp., Armonk, NY, USA) and Article Title: Efficacy of golimumab in patients with refractory non-infectious panuveitis Article Snippet: All statistical analyzes were performed using IBM SPSS Statistics version 29 (IBM Corp., Armonk, N.Y., USA) and Article Title: Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective Experience. Article Snippet: Article Title: Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study). Article Snippet: Statistical analyses were conducted using the |